Literature DB >> 1164607

Editorial: Paget's disease and calcitonin.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1164607      PMCID： PMC1674361          DOI： 10.1136/bmj.3.5982.505

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Deafness in Paget's diseases: effect of salmon calcitonin treatment.

Authors:  P M Grimaldi; S M Mohamedally; N J Woodhouse
Journal:  Br Med J       Date:  1975-06-28

2.  Paget's disease of bone; incidence and subclinical forms.

Authors:  D H COLLINS
Journal:  Lancet       Date:  1956-07-14       Impact factor: 79.321

3.  Radiological regression in Paget's disease treated by human calcitonin.

Authors:  N J Woodhouse; G F Joplin; I MacIntyre; F H Doyle
Journal:  Lancet       Date:  1972-11-11       Impact factor: 79.321

4.  Human calcitonin in the treatment of Paget's bone disease.

Authors:  N J Woodhouse; P Bordier; M Fisher; G F Joplin; M Reiner; D N Kalu; G V Foster; I MacIntyre
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

5.  Paget's sarcoma of bone. A study of eighty cases from the Bristol and the Leeds bone tumour registries.

Authors:  C H Price; W Goldie
Journal:  J Bone Joint Surg Br       Date:  1969-05

6.  An evaluation of antibodies and clinical resistance to salmon calcitonin.

Authors:  F R Singer; J P Aldred; R M Neer; S M Krane; J T Potts; K J Bloch
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease.

Authors:  W A Crosbie; S M Mohamedally; N J Woodhouse
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.